#72
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians should counsel male patients of reproductive age about cannabis use, as evidence demonstrates it reduces sperm count and quality, potentially impacting fertility outcomes. Patients planning conception should understand this reversible but clinically significant risk, making it an important discussion point during preconception counseling and general health assessments.
Recent research indicates that cannabis use may impair male fertility through mechanisms that reduce both sperm count and sperm quality, findings that clinicians should discuss with reproductive-age male patients during fertility counseling and risk assessment. The evidence suggests that cannabinoids may affect testicular function and spermatogenesis, potentially contributing to subfertility or infertility in men who use cannabis regularly. This represents an important but often overlooked counseling point, particularly given the increasing normalization and legalization of cannabis in many jurisdictions, which may reduce patient awareness of reproductive risks. Clinicians evaluating men with unexplained infertility or subfertility should routinely inquire about cannabis use patterns and consider this a modifiable risk factor for fertility optimization. Male patients of reproductive age who use cannabis should be informed of potential impacts on fertility and encouraged to discuss conception plans with their healthcare provider.
“In my two decades of practice, I’ve seen enough quality evidence to counsel men planning parenthood that regular cannabis use meaningfully suppresses spermatogenesis, and the effect is often reversible once they stop, which gives us a concrete pathway to help them restore fertility without pharmaceutical intervention.”
? While emerging evidence suggests cannabis use may impair male fertility through effects on sperm production and motility, the clinical significance remains uncertain given variability in study designs, dosing regimens, and duration of exposure across the literature. Men presenting with infertility or subfertility should be counseled that cannabis use is a potentially modifiable risk factor worth discussing, though it represents one of many lifestyle, environmental, and medical contributors that warrant evaluation. The relationship between cannabis and male fertility appears dose and frequency dependent, but most available data come from small studies or animal models, limiting definitive clinical guidance. In practice, providers can incorporate cannabis use history into routine fertility assessments and discuss cessation as a low-risk intervention for men concerned about reproductive health, while recognizing that individual responses vary and that further research is needed to establish causality and quantify clinical risk.
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
